Evaluating undercounts in epidemics: Response to Maruotti et al. (2022)
Published in Journal of Medical Virology
Evaluating undercounts in epidemics: Response to Maruotti et al. (2022)
Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS‐CoV‐2 Omicron variant...
Published in Journal of Medical Virology
"Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study": Author's reply.
Published in Journal of medical virology
Unveiling HERV-K113-ENV as SARS-CoV-2 severity admissible biomarker by mining transcriptome data.
Published in Journal of medical virology
Autoimmune seronegative limbic encephalitis following ChAdOx1-S/nCoV-19 vaccination in a patient with ankylosing spondyl...
Published in Journal of medical virology
Bioinformatics analysis of the s2m mutations within the SARS-CoV-2 Omicron lineages.
Published in Journal of medical virology
Whole-transcriptome sequencing data reveals a disparate cognitive and immune signature in COVID-19 patients with and wit...
Published in Journal of medical virology
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 6.3 million deaths worldwide. Recent evidence has indicated that elderly people with dementia are particularly vulnerable to COVID-19 and severe disease outcomes. However, its molecular mechanism remains lar...
Antiviral treatment of COVID-19 is associated with lack of immune response.
Published in Journal of medical virology
On the SARS-CoV-2 BA.2.75 variant: A genetic and structural point of view.
...Published in Journal of medical virology
Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome.
Published in Journal of medical virology
